Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01591733 | FOLFIRINOX + RT for Pancreatic Cancer | completed | Phase 2 | 48 | Massachusetts General HospitalOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT01972919 | MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer | completed | Phase 2 | 23 | Medical College of WisconsinOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| Mechlorethamine Induced Contact Dermatitis Avoidance Study(MIDAS) |
| completed |
| Phase 2 |
| 28 |
| Rochester Skin Lymphoma Medical Group, PLLCOTHER |
| 1 |
| Sep 4, 2026 |
| clinicaltrials |
| NCT03584334 | 18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma(FDG-IMMUN) | completed | N/A | 100 | Centre Antoine LacassagneOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT04016376 | Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction | completed | Phase 4 | 1,507 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT04427527 | Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia(ACCSIS) | completed | N/A | 29,772 | Mark Dignan, PhDOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT04909164 | The Prospective Non-randomized Case-control Study From Real-world Lung Cancer Patients(OPTIMUS) | completed | — | 1,519 | Myung-Ju AhnOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT05281380 | VITAMin Insufficiency in Esophagogastric Neoplasms(VITAMIN) | completed | N/A | 107 | Zuyderland Medisch CentrumOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT05816785 | Pilot Study of Imatinib Cetuximab Combo for H & N Cancer | completed | Early Phase 1 | 15 | University of Wisconsin, MadisonOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT06076291 | An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors(CSG-1827-101) | completed | Phase 1 | 19 | Hangzhou Sumgen Biotech Co., Ltd.INDUSTRY | 1 | Sep 4, 2026 | clinicaltrials |
| NCT06167486 | SG2918 For Advanced Malignant Tumors | completed | Phase 1 | 17 | Hangzhou Sumgen Biotech Co., Ltd.INDUSTRY | 1 | Sep 4, 2026 | clinicaltrials |
| NCT06390059 | EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma | completed | Phase 2 | 84 | NovoCure Ltd.INDUSTRY | 4 | Sep 4, 2026 | clinicaltrials |
| NCT06790355 | ProSight: A Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population | completed | N/A | 2,527 | Shanghai Weihe Medical Laboratory Co., Ltd.INDUSTRY | 1 | Sep 4, 2026 | clinicaltrials |
| NCT07724678 | Comparison of Combined (Superficial and Deep) and Isolated Deep Serratus Anterior Plane Blocks After Breast Surgery | completed | — | 76 | SBU Ankara Egitim ve Arastirma HastanesiOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT03657576 | Trial of C134 in Patients With Recurrent GBM(C134-HSV-1) | completed | Phase 1 | 19 | University of Alabama at BirminghamOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT03674567 | Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab | completed | Phase 1 / Phase 2 | 323 | RAPT Therapeutics, Inc.INDUSTRY | 6 | Sep 3, 2026 | clinicaltrials |
| NCT03856372 | Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer | completed | N/A | 1,494 | Fudan UniversityOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT04493060 | Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer | completed | Phase 2 | 22 | Mayo ClinicOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT05282459 | Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation | completed | Phase 1 / Phase 2 | 17 | Tian Yi ZhangOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT05840341 | Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer | completed | Phase 3 | 305 | Fudan UniversityOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT06170216 | Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL) | completed | — | 206 | Fudan UniversityOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT06439706 | HPV Self-sampling for Underscreened Latinas | completed | N/A | 108 | Fox Chase Cancer CenterOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT06470750 | Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP) | completed | — | 75 | Mayo ClinicOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT06827132 | Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer(CASCADE) | completed | — | 603 | AstraZenecaINDUSTRY | 2 | Sep 3, 2026 | clinicaltrials |
| NCT06837896 | Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer | completed | Phase 3 | 111 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 3, 2026 | clinicaltrials |
| NCT07802977 | Intraparenchymal Salivary Gland Corticosteroid Injection to Prevent Radiation-Induced Xerostomia | completed | Phase 1 | 10 | University of California, DavisOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT07803549 | The Effect of Self-Management Interventions Among Patients With Breast Cancer Related-Lymphedema((BCRL)) | completed | N/A | 100 | Al-Zaytoonah University of JordanOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT01261728 | Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma | completed | Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT02271828 | Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy | completed | N/A | 1,644 | Maastricht University Medical CenterOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT02455245 | A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma | completed | Phase 3 | 95 | Alicia LenzenOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT02657486 | BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder | completed | N/A | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT02794428 | Chemoprevention of Gastric Carcinogenesis | completed | Phase 2 | 91 | Vanderbilt-Ingram Cancer CenterOTHER | 2 | Sep 2, 2026 | clinicaltrials |
| NCT03502785 | INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma | completed | Phase 1 / Phase 2 | 35 | Inovio PharmaceuticalsINDUSTRY | 1 | Sep 2, 2026 | clinicaltrials |
| NCT03691714 | Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 | 35 | University of CincinnatiOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT04276493 | Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab | completed | Phase 1 / Phase 2 | 71 | BeiGeneINDUSTRY | 3 | Sep 2, 2026 | clinicaltrials |
| NCT04330820 | Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)(RELAX) | completed | Phase 1 / Phase 2 | 55 | Technische Universität DresdenOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT04530916 | Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal Women(WB2020) | completed | Phase 1 / Phase 2 | 58 | Colorado State UniversityOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT04962919 | Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.(LACOG 1818) | completed | — | 584 | Latin American Cooperative Oncology GroupOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT05709197 | The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy(REMBRANDT) | completed | N/A | 256 | Radboud University Medical CenterOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT05721846 | Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer(CheckVAC) | completed | Phase 1 | 20 | Inna Chen, MDOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT05864144 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 98 | Sensei Biotherapeutics, Inc.INDUSTRY | 1 | Sep 2, 2026 | clinicaltrials |
| NCT05900882 | SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease | completed | Phase 2 | 29 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT05942794 | Identification of Oral Lesions Through an Autofluorescence System | completed | N/A | 200 | Federico II UniversityOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT05993299 | Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma | completed | Phase 2 | 7 | USWM, LLC (dba US WorldMeds)INDUSTRY | 7 | Sep 2, 2026 | clinicaltrials |
| NCT06279442 | Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort | completed | — | 150 | Latin American Cooperative Oncology GroupOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT06495463 | Lonsurf® (Trifluridine/Tipiracil) Plus Chemotherapy in Metastatic Colorectal Cancer Prospective Study in Taiwan | completed | N/A | 97 | Chang Gung Memorial HospitalOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07656311 | Mean Platelet Volume (MPV) as an Early Predictor of Mortality in Intensive Care Patients With Cancer(MPV-CICU) | completed | — | 425 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07798895 | Opioid-Free Versus Opioid-Based Anesthesia in Modified Radical Mastectomy | completed | N/A | 28 | Muhammad Fiqhi AmiruddinOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT00086567 | Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers | completed | — | 119 | National Cancer Institute (NCI)NIH | 1 | Sep 1, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Sep 4, 2026source: clinicaltrials